drugset / Trial / NCT04080310
Efficacy and Safety of Combination Therapy of Moderate-intensity Statin and Ezetimibe Compared to High-intensity Statin
Phase 4
Completed
270 enrolled
Seoul National University Bundang Hospital
Yuhan Corporation · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
This study is a multicenter, randomized, open-label, parallel, phase IV trial. The purpose of this study efficacy and safety of combination therapy of moderate-intensity statin and ezetimibe compared to high-intensity statin.
Timeline
- Start
- 2018-03-15
- Primary completion
- 2019-06-15
- Completion
- 2019-09-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ezetimibe | Unknown | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |